아시아태평양의 군유전체학 시장 : 유형별, 용도별, 국가별 분석과 예측(2024-2033년)

Introduction to Asia-Pacific (APAC) Metagenomics Market

The Asia-Pacific metagenomics market was valued at $376.1 million in 2023 and is expected to reach $2,238.0 million by 2033, growing at a CAGR of 19.65% between 2024 and 2033. The metagenomics market in Asia-Pacific (APAC) is expanding rapidly, driven by its ability to examine microbial communities that cannot be grown in laboratory. By studying microbial genomes directly from environmental samples using genomic analysis methods, metagenomics is revolutionizing our knowledge of microbial diversity and function. Improvements in sequencing technologies, growing knowledge of the health effects of microbes, and the widespread use of metagenomics in industries including biotechnology, agriculture, and environmental preservation are major drivers of this market's growth.

The demand for novel enzymes and antibiotics, as well as the growing interest in customized medicine, are driving the market's expansion in Asia Pacific. Metagenomics is becoming an essential tool for both scientific research and commercial applications because of its capacity to reveal important information about microbial ecosystems.

Market Introduction

The market for metagenomics in Asia-Pacific (APAC) is expanding significantly due to the growing need for sophisticated genomic analysis to comprehend microbial populations. Our understanding of microbial diversity and roles has been completely transformed by metagenomics, which makes it possible to analyze microbial genomes directly from environmental samples. This is particularly true in areas where conventional lab culture techniques are not readily available. As a result, APAC has seen notable advancements in a number of areas, including healthcare, agriculture, biotechnology, and environmental management.

This market is primarily driven by developments in bioinformatics tools and next-generation sequencing (NGS) technology. Metagenomics research and applications have been further stimulated by the increasing recognition of the effects of microbes on human health, agricultural productivity, and environmental restoration. The need to address developing diseases, the need for tailored therapy, and the development of new antibiotics have also spurred the market's growth.

Furthermore, the metagenomics market is expected to grow steadily as APAC economies make significant investments in scientific research and development. The technology is a vital tool for innovation in sectors that depend on an understanding of microbiomes for sustainable solutions because of its unrealized potential in analyzing complex microbial ecosystems.

Market Segmentation

Segmentation 1: by Product Type

• Consumables
• Instruments
• Services and Software

Segmentation 2: by Application

• Clinical Diagnostics
• Industrial Applications
• Research Applications

Segmentation 3: by Country

• Japan
• India
• China
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The APAC metagenomics market has been segmented based on various categories, such as product type, workflow, technology, application, and country.

Competitive Strategy: Key players are investing heavily in research and development to enhance their product portfolios and develop cutting-edge technologies for sample preparation, sequencing, and analysis. Strategic collaborations with academic institutions, research organizations, and industry partners are also key, facilitating access to diverse datasets and expertise. Furthermore, companies are focusing on expanding their market presence through geographic expansion and strategic acquisitions to capitalize on emerging opportunities and consolidate their market position.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• BGI Genomics
• MGI Tech Co., Ltd.
• Macrogen, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Ecosystem Overview: Metagenomics Market
• 1.2 Trends: Current and Future Impact Assessment
  • 1.2.1 Expansion into New Application Areas
  • 1.2.2 Increasing Collaborations and Partnerships among Key Players
• 1.3 Research and Development Review
  • 1.3.1 Patent Filing Trend (by Country, Company)
• 1.4 Regulatory Landscape
• 1.5 Market Dynamics
  • 1.5.1 Market Drivers
    • 1.5.1.1 Significant Reduction in Sequencing Costs Leading to an Increase in the Number of Metagenomics Studies
    • 1.5.1.2 High Incidence of Infectious Diseases
    • 1.5.1.3 Technological Advancements in Metagenomics
  • 1.5.2 Market Restraints
    • 1.5.2.1 Challenge of Securely Storing Vast Volumes of Sequenced Data
    • 1.5.2.2 Challenges Involved in Data Analysis of Metagenomics Sequencing and Lack of Clear Knowledge
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Opportunity for Metagenomics in Microplastic Remediation
    • 1.5.3.2 Focus on Metagenomics Research on Antibiotic-Resistant Bacteria and Antibiotic-Resistant Genes

2 Regions

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Asia-Pacific
  • 2.3.1 Regional Overview
  • 2.3.2 Factors Driving the Market Growth
  • 2.3.3 Factors Impeding/Limiting the Market Growth
  • 2.3.4 By Type
  • 2.3.5 By Application
  • 2.3.6 China
    • 2.3.6.1 By Type
    • 2.3.6.2 By Application
  • 2.3.7 Japan
    • 2.3.7.1 By Type
    • 2.3.7.2 By Application
  • 2.3.8 India
    • 2.3.8.1 By Type
    • 2.3.8.2 By Application
  • 2.3.9 Australia
    • 2.3.9.1 By Type
    • 2.3.9.2 By Application
  • 2.3.10 South Korea
    • 2.3.10.1 By Type
    • 2.3.10.2 By Application
  • 2.3.11 Rest-of-Asia-Pacific
    • 2.3.11.1 By Type
    • 2.3.11.2 By Application

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Active Key Players in The Ecosystem
• 3.3 Key Strategies and Developments
  • 3.3.1 BGI Genomics
    • 3.3.1.1 Overview
    • 3.3.1.2 Top Products
    • 3.3.1.3 Top Competitors
    • 3.3.1.4 Key Personnel
    • 3.3.1.5 Analyst View
  • 3.3.2 MGI Tech Co., Ltd.
    • 3.3.2.1 Overview
    • 3.3.2.2 Top Products/Product Portfolio
    • 3.3.2.3 Top Competitors
    • 3.3.2.4 Key Personnel
    • 3.3.2.5 Analyst View
  • 3.3.3 Macrogen, Inc.
    • 3.3.3.1 Overview
    • 3.3.3.2 Top Products/Product Portfolio
    • 3.3.3.3 Top Competitors
    • 3.3.3.4 Key Personnel
    • 3.3.3.5 Analyst View
  • 3.3.4 Emerging Companies in the Metagenomics Market

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast